Patents by Inventor Peter Gruss

Peter Gruss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Contact device, electrical component unit, method, and use of a contact device in an electrical component unit
    Publication number: 20240097370
    Abstract: A contact device includes a first plug connector, which for forming a plug contact is pluggable onto a corresponding second plug connector of a first component, and comprising at least one first abutment section, which for forming a pressure contact is pressable against a second abutment section of a second component and/or of an additional element that is connectable to the second component. At least one spring section is provided between the first plug connector and the first abutment section and/or between a fastening section of the additional element and the second abutment section. The spring section presses the two abutment sections against one another with an elastic force when the two components are electrically connected to one another. The first plug connector is designed as a push-on sleeve, so that it is pluggable onto a second plug connector, designed as a plug, of the first component.
    Type: Application
    Filed: September 15, 2023
    Publication date: March 21, 2024
    Applicant: OECHSLER AG
    Inventors: Friedrich KLEEBERGER, Martin DANNER, Steffen NEUMANN, Peter STANISLAWSKI, Denise HURTIENNE, Heinz SOELLINGER, Ganime MURAD, Edwin SCHOENROCK, Dominic GRUSS
  • Method for testing the differentiation status in pancreatic cells of a mammal
    Patent number: 6071697
    Abstract: The present invention relates to a novel method for testing the developmental status in pancreatic cells of a mammal. The present invention further relates to applications in the medical field that directly arise from the method of the invention. Additionally, the present invention relates to transgenic mammals comprising at least one inactivated Pax4 allele and optionally at least one inactivated Pax6 allele.
    Type: Grant
    Filed: December 31, 1996
    Date of Patent: June 6, 2000
    Assignee: Max-Planck Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Beatriz Sosa-Pineda, Peter Gruss
  • Pax6 and Pax4 nucleic acid mixtures
    Patent number: 6028184
    Abstract: The present invention relates to a novel method for testing the developmel status in pancreatic cells of a mammal. The present invention further relates to applications in the medical field that directly arise from the method of the invention. Additionally, the present invention relates to transgenic mammals comprising at least one inactivated Pax6 allele and optionally at least one inactivated Pax4 allele.
    Type: Grant
    Filed: December 31, 1996
    Date of Patent: February 22, 2000
    Assignee: Max-Plank-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Peter Gruss, Luc St.-Onge
  • Method for testing the differentiation status in pancreatic cells of a mammal
    Patent number: 5948623
    Abstract: The present invention relates to a novel method for testing the developmental status in pancreatic cells of a mammal. The present invention further relates to applications in the medical field that directly arise from the method of the invention. Additionally, the present invention relates to transgenic mammals comprising at least one inactivated Pax4 allele and optionally at least one inactivated Pax6 allele.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: September 7, 1999
    Assignee: Max-Planck Gesellschaft Zur Forderung der Wissenschaften E.V.
    Inventors: Beatriz Sosa-Pineda, Peter Gruss
  • Mixtures leading to hard polyurethane foamed materials
    Patent number: 5869546
    Abstract: Mixtures leading to hard polyurethane foamed materials, which mixtures are preferably present in a pressure vessel, containa) prepolymers containing isocyanate groups, obtainable by the reaction of polyisocyanates containing isocyanurate groups and optionally urethane groups with compounds having at least two hydrogen atoms which are reactive to isocyanates and having a molecular weight of 62 to 10,000, wherein the content of monomeric polyisocyanate in the prepolymer is less than 2 weight %,b) auxiliary process materials and additives known in the art, andc) foaming agents having a boiling point less than 0.degree. C./760 mm Hg.
    Type: Grant
    Filed: September 20, 1996
    Date of Patent: February 9, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Peter Gruss, Manfred Kapps, Peter Vehlewald, Rainer Rettig
  • Probe for tumour diagnostics or tumour therapy
    Patent number: 5747250
    Abstract: A therapeutic or diagnostic agent according to the invention contains as active substance at least one nucleic acid which hybridizes with a Pax gene or at least one Pax protein or at least one antibody against a Pax protein or a derivative thereof. The agents according to the invention are used in tumour diagnosis or/and tumour therapy as well as an antisense nucleic acid for the inhibition of gene expression.
    Type: Grant
    Filed: March 27, 1995
    Date of Patent: May 5, 1998
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
    Inventors: Peter Gruss, Catharina Maulbecker